This compound is a pharmaceutical intermediate consisting of a tert-butyl carbamate-protected amino alcohol combined with succinic acid as a salt-forming agent. It is used in research and manufacturing settings for the synthesis of more complex active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 169870-02-4
Bdh succinate
Pharmaceutical intermediate for HIV protease inhibitors
Carbamic acid, N-[(1S,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-, 1,1-dimethylethyl ester
Pharmaceutical intermediate for peptide synthesis
Methyl 4,4'-biphenyl-R-alanate
Pharmaceutical intermediate for drug synthesis
(4'-Methyl-3-fluoro[1,1'-biphenyl]-4-yl)-boronic acid
pharmaceutical intermediate
(5R)-ethyl 5-((1R,3aS,7aR)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethyl)-7a-methyloctahydro-1H-inden-1-yl)hexanoate
Calcitriol intermediate
2,4-Dichloro-6-phenyl-1,3,5-triazine
Pharmaceutical intermediate
(3-(6-Phenylhexyl)phenyl)boronic acid
n.a
1,6-Diphenylhexane
n.a
butanedioic acid;tert-butyl N-[(2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl]carbamate
ZICUGSIJUKRRJL-OCIDDWSYSA-N
CC(C)(C)OC(=O)N[C@@H](CC1=CC=CC=C1)C[C@@H]([C@H](CC2=CC=CC=C2)N)O.C(CC(=O)O)C(=O)O